Skip to main content
. 2021 Mar 1;11(3):837–848.

Table 1.

Study cohort clinicopathological parameters

Testing Set Validation Set1 (Serum) Validation Set2 (Tissue)



PDAC patients (N = 6) Healthy controls (N = 6) PDAC patients (N = 110) Healthy controls (N = 100) PDAC patients (N = 51)
male 3 (50) 5 (83) 75 (68) 47 (47) 33 (64.71)
female 3 (50) 1 (17) 35 (32) 53 (53) 18 (35.29)
62.3 (48-70) 33.4 (26-42) 63.3 (48-73) 34.19 (21-63) 62.88 (44-85)
I 0 Not applicable 24 Not applicable 14
II 1 36 16
III 4 18 15
IV 1 22 6
N.A. 0 10 0